A podcast series lets listeners eavesdrop on a conversation between scientists in a bar

The EMA says “yes” to transparency, but some pharma companies have other ideas.

Are reduced GDUFA fees on the horizon for contract manufacturers?

Lyophilized gene networks synthesize biomedicines ondemand – with just a sprinkle of water.

The original goal of 'Obamacare' was to increase access to health insurance, but has it worked?

It's Trump or Clinton for President. But what are the implications for pharma?

Researchers say cancer should involve more frequent treatment at lower doses.

With illegal drug use rising, can a cancer drug be repurposed to cure cocaine addiction?

Not all successful biosimilar applications in Europe follow guidelines to the letter

Researchers call for more oversight as some pharma companies cozy up to hemophilia patients.